LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.12) by 175 percent. The company reported quarterly sales of $53.393 million which missed the analyst consensus estimate of $53.802 million by 0.76 percent. This is a 38.27 percent increase over sales of $38.614 million the same period last year.